ImageneBio (IMA) Equity Ratio (2020 - 2025)

ImageneBio has disclosed Equity Ratio across 6 years of filings, most recently posting 0.87 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.87, up 108.63% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.87 (up 108.63% YoY), and the FY2025 annual result was 0.87, up 108.63% from the prior year.
• Equity Ratio came in at 0.87 for Q4 2025 at ImageneBio, roughly flat from 0.87 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.91 in Q2 2023 to a low of 10.08 in Q4 2024.
• The 5-year median for Equity Ratio is 0.78 (2021), against an average of 0.27.
• Across the five-year window, Equity Ratio jumped 239.76% in 2021 and plunged 1436.1% in 2024, its largest moves.
• ImageneBio's Equity Ratio stood at 0.84 in 2021, then rose by 1.74% to 0.85 in 2022, then tumbled by 176.95% to 0.66 in 2023, then slumped by 1436.1% to 10.08 in 2024, then soared by 108.63% to 0.87 in 2025.
• The last three Equity Ratio figures came in at 0.87 (Q4 2025), 0.87 (Q3 2025), and 1.43 (Q2 2025), per Business Quant data.